111 related articles for article (PubMed ID: 1390347)
21. Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil.
Brentani A; de Castro G; Federico MH
Head Neck; 2011 Aug; 33(8):1199-205. PubMed ID: 21755563
[TBL] [Abstract][Full Text] [Related]
22. Intensive care, survival, and expense of treating critically ill cancer patients.
Schapira DV; Studnicki J; Bradham DD; Wolff P; Jarrett A
JAMA; 1993 Feb; 269(6):783-6. PubMed ID: 8423662
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression.
Thomas KC; Nosyk B; Fisher CG; Dvorak M; Patchell RA; Regine WF; Loblaw A; Bansback N; Guh D; Sun H; Anis A
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1212-8. PubMed ID: 17145536
[TBL] [Abstract][Full Text] [Related]
24. A cost-effectiveness and cost-utility study of lung transplantation.
Vasiliadis HM; Collet JP; Penrod JR; Ferraro P; Poirier C
J Heart Lung Transplant; 2005 Sep; 24(9):1275-83. PubMed ID: 16143245
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: implications from five randomized trials.
Rose PG; Lappas PT
Gynecol Oncol; 2000 Jul; 78(1):3-6. PubMed ID: 10873400
[TBL] [Abstract][Full Text] [Related]
26. Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma.
Ghosh S; Baker S; de Castro DG; Kepka L; Kumar N; Sinaika V; Matiello J; Lomidze D; Dyttus-Cebulok K; Rosenblatt E; Fidarova E; Roa W
Radiother Oncol; 2018 Apr; 127(1):114-120. PubMed ID: 29452901
[TBL] [Abstract][Full Text] [Related]
27. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
28. A model for calculating the costs of in vivo dosimetry and portal imaging in radiotherapy departments.
Kesteloot K; Dutreix A; van der Schueren E
Radiother Oncol; 1993 Aug; 28(2):108-17. PubMed ID: 8248551
[TBL] [Abstract][Full Text] [Related]
29. Estimated cost of person-Sv exposure.
Guenther CF; Thein C
Health Phys; 1997 Feb; 72(2):204-21. PubMed ID: 9003706
[TBL] [Abstract][Full Text] [Related]
30. Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.
Leighl NB; Shepherd FA; Kwong R; Burkes RL; Feld R; Goodwin PJ
J Clin Oncol; 2002 Mar; 20(5):1344-52. PubMed ID: 11870178
[TBL] [Abstract][Full Text] [Related]
31. [The analysis of drug cost and direct medical expense in community health management of hypertensive patients].
Liang XH; Gu DF; Zhang H; Zhu K; Deng Y; Cao J; Zhou ZY; Wang Y; Wan GS; Zhao C; Mu QC; Lu FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):732-6. PubMed ID: 22169696
[TBL] [Abstract][Full Text] [Related]
32. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema.
Ramsey SD; Berry K; Etzioni R; Kaplan RM; Sullivan SD; Wood DE;
N Engl J Med; 2003 May; 348(21):2092-102. PubMed ID: 12759480
[TBL] [Abstract][Full Text] [Related]
33. Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).
Konski A; Sherman E; Krahn M; Bremner K; Beck JR; Watkins-Bruner D; Pilepich M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):788-94. PubMed ID: 16109464
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.
Angus DC; Linde-Zwirble WT; Clermont G; Ball DE; Basson BR; Ely EW; Laterre PF; Vincent JL; Bernard G; van Hout B;
Crit Care Med; 2003 Jan; 31(1):1-11. PubMed ID: 12544986
[TBL] [Abstract][Full Text] [Related]
35. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
36. Cost accounting in radiation oncology: a computer-based model for reimbursement.
Perez CA; Kobeissi B; Smith BD; Fox S; Grigsby PW; Purdy JA; Procter HD; Wasserman TH
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):895-906. PubMed ID: 8478242
[TBL] [Abstract][Full Text] [Related]
37. [Economic evaluation of radiotherapy: methods and results].
Durand-Zaleski I
Cancer Radiother; 2005 Nov; 9(6-7):449-51. PubMed ID: 16219481
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
Suh WW; Hillner BE; Pierce LJ; Hayman JA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1054-61. PubMed ID: 15752884
[TBL] [Abstract][Full Text] [Related]
39. Cost-minimization analysis: radiation treatment with and without a multi-leaf collimator.
Foroudi F; Lapsley H; Manderson C; Yeghiaian-Alvandi R
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1443-8. PubMed ID: 10889400
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
